{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:28:41Z","timestamp":1791286121235,"version":"4.1.0"},"reference-count":47,"publisher":"American Association of Zoo Veterinarians","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Zoo and Wildlife Medicine"],"published-print":{"date-parts":[[2021,6,11]]},"DOI":"10.1638\/2020-0161","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:05:38Z","timestamp":1623409538000},"source":"Crossref","is-referenced-by-count":6,"title":["PLASMA VORICONAZOLE CONCENTRATIONS FOLLOWING SINGLE- AND MULTIPLE-DOSE SUBCUTANEOUS INJECTIONS IN WESTERN POND TURTLES (ACTINEMYS MARMORATA)"],"prefix":"10.1638","volume":"52","author":[{"given":"Thomas L.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenessa","family":"Gjeltema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund F.","family":"Wack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Woodburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Tell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1213","reference":[{"key":"22","doi-asserted-by":"crossref","unstructured":"DM Lindemann, MC Allender, M Rzadkowska, et al.  \"J Zoo Wildl Med.\"  48, \"Pharmacokinetics, efficacy, and safety of voriconazole and itraconazole in healthy cottonmouths (Agkistrodon piscivorus) and massasauga rattlesnakes (Sistrurus catenatus) with snake fungal disease.\" 757 (2017)","DOI":"10.1638\/2016-0179.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"CS Chung, CH Cheng, SC Chin, et al.  \"J Zoo Wildl Med.\"  40, \"Morphologic and cytochemical characteristics of Asian yellow pond turtle (Ocadia sinensis) blood cells and their hematologic and plasma biochemical reference values.\" 76 (2009)","DOI":"10.1638\/2008-0023.1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"T Hellebuyck, K Baert, F Pasmans, et al.  \"Vet Dermatol.\"  21, \"Cutaneous hyalohyphomycosis in a girdled lizard (Cordylus giganteus) caused by the Chrysosporium anamorph of Nannizziopsis vriesii and successful treatment with voriconazole.\" 429 (2010)","DOI":"10.1111\/j.1365-3164.2010.00880.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"CJ Innis, D Young, S Wetzlich, et al.  \"J Herpetol Med Surg.\"  24, \"Plasma concentrations and safety assessment of voriconazole in red-eared slider turtles (Trachemys scripta elegans) after single and multiple subcutaneous injections.\" 28 (2014)","DOI":"10.5818\/1529-9651-24.1.28"},{"key":"46","doi-asserted-by":"crossref","unstructured":"DB Woodburn, AN Miller, MC Allender, et al.  \"J Clin Microbiol.\"  57, \"Emydomyces testavorans, a new genus and species of onygenalean fungus isolated from shell lesions of freshwater aquatic turtles.\" e00628 (2019)","DOI":"10.1128\/JCM.00628-18"},{"key":"1","doi-asserted-by":"crossref","unstructured":"MR Bowman, JA Par\u00e9, L Sigler, et al.  \"Med Mycol.\"  45, \"Deep fungal dermatitis in three inland bearded dragons (Pogona vitticeps) caused by the Chrysosporium anamorph of Nannizziopsis vriesii.\" 371 (2007)","DOI":"10.1080\/13693780601188610"},{"key":"2","doi-asserted-by":"crossref","unstructured":"AE Boyd, S Modi, SJ Howard, et al.  \"Clin Infect Dis.\"  39, \"Adverse reactions to voriconazole.\" 1241 (2004)","DOI":"10.1086\/424662"},{"key":"3","unstructured":"M. Brooks,  \"Proceedings of the Chelonian Advisory Group.\"  , \"Freshwater Turtle Nutrition: The Case of the Western Pond Turtle.\"  (2017)"},{"key":"4","unstructured":"GR Browning, J Gjeltema, L Wright, et al.  \"Proc Am Assoc Zoo Vet.\"  , \"Fungal shell disease associated with Emdydomyces testavorans in a zoo collection of Western pond turtles (Actinemys marmorata).\" 30 (2019)"},{"key":"5","unstructured":"H. Chan,  \"Pharmacokinetics of voriconazole in horses and alpacas.\"  ,  (2008)"},{"key":"7","doi-asserted-by":"crossref","unstructured":"JL Davis, JH Salmon, MG Papich,  \"Am J Vet Res.\"  67, \"Pharmacokinetics of voriconazole after oral and intravenous administration to horses.\" 1070 (2006)","DOI":"10.2460\/ajvr.67.6.1070"},{"key":"8","doi-asserted-by":"crossref","unstructured":"KR Ferrier, CE van Elk, PE Bunskoek, et al.  \"Med Mycol.\"  55, \"Dosing and therapeutic drug monitoring of voriconazole in bottlenose dolphins (Tursiops truncatus).\" 155 (2017)","DOI":"10.1093\/mmy\/myw062"},{"key":"9","doi-asserted-by":"crossref","unstructured":"AW. Fothergill,  \"Interactions of yeasts, moulds, and antifungal agents.\"  , \"Antifungal susceptibility testing: clinical laboratory and standards institute (CLSI) methods.\" 65 (2012)","DOI":"10.1007\/978-1-59745-134-5_2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"LE Friberg, P Ravva, MO Karlsson, et al.  \"Antimicrob Agents Chemother.\"  56, \"Integrated population pharmacokinetic analysis of voriconazole in children, adolescents, and adults.\" 3032 (2012)","DOI":"10.1128\/AAC.05761-11"},{"key":"11","doi-asserted-by":"crossref","unstructured":"JJ Green  and SM Manders  \"J Am Acad Dermatol.\"  44, \"Pseudoporphyria.\" 100 (2001)","DOI":"10.1067\/mjd.2000.111338"},{"key":"12","unstructured":"B Groves, K Haman, DR Reavill,  \"Proceedings of the Association of Reptilian and Amphibian Veterinarians.\"  2016, \"Nannizziopsiaceae spp. infection in aquatic chelonians.\" 799 (2016)"},{"key":"13","unstructured":"LA Hallock, A McMillan, GJ Wiles,  \"Periodic status review for the Western Pond Turtle in Washington.\"  , 30 (2017)"},{"key":"14","unstructured":"KH Haman, L Hallock, T Schmidt, et al.  \"Herpetol Rev.\"  50, \"Shell disease in Northwestern pond turtles (Actinemys marmorata) in Washington state, USA.\" 495 (2019)"},{"key":"15","doi-asserted-by":"crossref","unstructured":"JH Heatley  and KE Russell  \"Mader's reptile and amphibian medicine and surgery.\"  , \"Hematology.\" 301 (2019)","DOI":"10.1016\/B978-0-323-48253-0.00033-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"R. Herbrecht,  \"Expert Rev Anti-Infect Ther.\"  2, \"Voriconazole: therapeutic review of a new azole antifungal.\" 485 (2004)","DOI":"10.1586\/14787210.2.4.485"},{"key":"18","unstructured":"E Holman  and D Anderson  \"Western Pond Turtle Project report, 2012.\"  , 15 (2013)"},{"key":"20","doi-asserted-by":"crossref","unstructured":"RE. Lewis,  \"Mayo Clinic Proc.\"  86, \"Current concepts in antifungal pharmacology.\" 805 (2011)","DOI":"10.4065\/mcp.2011.0247"},{"key":"21","doi-asserted-by":"crossref","unstructured":"AJ Lepak  and DR Andes  \"Cold Spring Harbor Perspect Med.\"  5, \"Antifungal pharmacokinetics and pharmacodynamics.\" 1 (2015)","DOI":"10.1101\/cshperspect.a019653"},{"key":"23","doi-asserted-by":"crossref","unstructured":"P Liu  and DR Mould  \"Antimicrob Agents Chemother.\"  58, \"Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.\" 4718 (2014)","DOI":"10.1128\/AAC.02808-13"},{"key":"24","doi-asserted-by":"crossref","unstructured":"S Miyakis, SJ Van Hal, J Ray, et al.  \"Clin Microbiol Infect.\"  16, \"Voriconazole concentrations and outcome of invasive fungal infections.\" 927 (2010)","DOI":"10.1111\/j.1469-0691.2009.02990.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"B Moriyama, J Elinoff, RL Danner, et al.  \"Antimicrob Agents Chemother.\"  53, \"Accelerated metabolism of voriconazole and its partial reversal by cimetidine.\" 1712 (2009)","DOI":"10.1128\/AAC.01221-08"},{"key":"26","doi-asserted-by":"crossref","unstructured":"T Pag\u00e9s, VI Peinado, G Viscor,  \"Comp Biochem Physiol A.\"  103, \"Seasonal changes in hematology and blood chemistry of the freshwater turtle Mauremys caspica leprosa.\" 275 (1992)","DOI":"10.1016\/0300-9629(92)90579-F"},{"key":"27","doi-asserted-by":"crossref","unstructured":"RA Parsley, LA Tell, R Gehring,  \"Am J Vet Res.\"  78, \"Pharmacokinetics of a single dose of voriconazole administered orally with and without food to red-tailed hawks (Buteo jamaicensus).\" 433 (2017)","DOI":"10.2460\/ajvr.78.4.433"},{"key":"28","doi-asserted-by":"crossref","unstructured":"A Pascual, C Csajka, T Buclin, et al.  \"Clin Infect Dis.\"  55, \"Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics\u2013based analysis of adult patients with invasive fungal infections.\" 381 (2012)","DOI":"10.1093\/cid\/cis437"},{"key":"29","unstructured":"et al.  \"Plumb's veterinary drug handbook.\"  ,  (2015)"},{"key":"30","doi-asserted-by":"crossref","unstructured":"JM Quimby, SB Hoffman, J Duke, et al.  \"J Vet Int Med.\"  24, \"Adverse neurologic events associated with voriconazole use in 3 cats.\" 647 (2010)","DOI":"10.1111\/j.1939-1676.2010.00504.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"SJ Roffey, S Cole, P Comby, et al.  \"Drug Metab Dispos.\"  31, \"The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human.\" 731 (2003)","DOI":"10.1124\/dmd.31.6.731"},{"key":"32","unstructured":"D Rosenberg, J Gervais, D Vesely, et al.  \"Conservation assessment of the Western Pond Turtle in Oregon (Actinemys marmorata), Executive Summary.\"  ,  (2009)"},{"key":"33","unstructured":"T Schmidt  and M Tirhi  \"Western Pond Turtle head-starting and reintroduction, South Puget Sound, Pierce County, Washington.\"  ,  (2014)"},{"key":"34","doi-asserted-by":"crossref","unstructured":"MT Sharp  and TD Horn  \"J Am Acad Dermatol.\"  53, \"Pseudoporphyria induced by voriconazole.\" 341 (2005)","DOI":"10.1016\/j.jaad.2005.03.030"},{"key":"35","doi-asserted-by":"crossref","unstructured":"J Smith, N Safdar, V Knasinski, et al.  \"Antimicrob Agents Chemother.\"  50, \"Voriconazole therapeutic drug monitoring.\" 1570 (2006)","DOI":"10.1128\/AAC.50.4.1570-1572.2006"},{"key":"36","unstructured":"et al.  \"Zoological Information Management System: Expected test results. Western pond turtle (Actinemys marmorata).\"  ,  ()"},{"key":"37","doi-asserted-by":"crossref","unstructured":"K Tan, N Brayshaw, K Tomaszewski, et al.  \"J Clin Pharmacol.\"  46, \"Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.\" 235 (2006)","DOI":"10.1177\/0091270005283837"},{"key":"38","doi-asserted-by":"crossref","unstructured":"JP Tolland, PP McKeown, JR Corbett,  \"Photodermatol Photoimmunol Photomed.\"  23, \"Voriconazole-induced pseudoporphyria.\" 29 (2007)","DOI":"10.1111\/j.1600-0781.2007.00263.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"PF Troke, HP Hockey, W Hope,  \"Antimicrob Agents Chemother.\"  55, \"Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients.\" 4782 (2011)","DOI":"10.1128\/AAC.01083-10"},{"key":"40","unstructured":"et al.  \"Actinemys marmorata. The IUCN Red List of Threatened Species 1996.\"  ,  ()"},{"key":"41","doi-asserted-by":"crossref","unstructured":"S Van Leuven, H Allen, K Slavens, et al.  \"Western Pond Turtle head-starting and reintroduction annual report for October 2005\u2013September 2006.\"  ,  (2006)","DOI":"10.2172\/903102"},{"key":"42","doi-asserted-by":"crossref","unstructured":"L Van Waeyenberghe, K Baert, F Pasmans, et al.  \"Sabouraudia.\"  48, \"Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).\" 880 (2010)","DOI":"10.3109\/13693781003743122"},{"key":"43","doi-asserted-by":"crossref","unstructured":"WM Vander Haegen, SL Clark, KM Perillo, et al.  \"J Wildl Manage.\"  73, \"Survival and causes of mortality of head-starting Western Pond Turtles on Pierce National Wildlife Refuge, Washington.\" 1402 (2009)","DOI":"10.2193\/2008-484"},{"key":"44","unstructured":"D Woodburn, L Naples, C Poll, et al.  \"Proceedings of the Assoc Rep Amphib Vet.\"  , \"Nannizziopsiaceae spp. infection in aquatic chelonians.\" 13 (2014)"},{"key":"45","unstructured":"DB Woodburn, MJ Kinsel, CP Poll, et al.  \"Vet Pathol.\"  , \"Shell lesions associated with Emydomyces testavorans infection in freshwater aquatic turtles.\"  ()"},{"key":"47","doi-asserted-by":"crossref","unstructured":"PY Yang, PH Yu, SH Wu, et al.  \"J Zoo Wildl Med.\"  45, \"Seasonal hematology and plasma biochemistry reference range values of the yellow-marginated box turtle (Cuora flavomarginata).\" 278 (2014)","DOI":"10.1638\/2013-0125R1.1"}],"container-title":["Journal of Zoo and Wildlife Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T11:07:01Z","timestamp":1623409621000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/journal-of-zoo-and-wildlife-medicine\/volume-52\/issue-2\/2020-0161\/PLASMA-VORICONAZOLE-CONCENTRATIONS-FOLLOWING-SINGLE--AND-MULTIPLE-DOSE-SUBCUTANEOUS\/10.1638\/2020-0161.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1638\/2020-0161","relation":{},"ISSN":["1042-7260"],"issn-type":[{"value":"1042-7260","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,11]]}}}